Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Blood cancers, Leukaemia
Closed
Phase 2
This trial is looking at a drug called midostaurin (also known as PKC412) for people who have mast cell leukaemia or a condition called systemic mastocytosis.
Recruitment start: 17 June 2009
Recruitment end: 8 June 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Reilly
Experimental Cancer Medicine Centre (ECMC)
Novartis
Last reviewed: 23 July 2014
CRUK internal database number: 5010
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
